Benzetacil

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Benzetacil

Quick Facts

Property Description
Active ingredient Benzathine Benzylpenicillin (Penicillin G Benzathine)
Form Powder for suspension for intramuscular injection
Pharmacological class Beta-lactam antibiotic (Anti-infective agent)
Common use Elimination and prophylaxis of susceptible bacterial infections
Origin Semi-synthetic derivative

Identity and Pharmacological Class

Benzetacil is a trade name for a highly established medicine whose active ingredient is Benzathine Benzylpenicillin, formally known as Penicillin G Benzathine. This drug is definitively classified as a beta-lactam antibiotic belonging to the penicillin group. The medication is globally recognized as an anti-infective agent and is derived as a semi-synthetic compound based on the original structure of natural penicillin. The drug’s critical status is affirmed by its inclusion on the World Health Organization's Model List of Essential Medicines, underscoring its importance in public health.

Composition and Depot Formulation

The active ingredient, Benzathine Benzylpenicillin, is supplied as a sterile powder for suspension for injection, requiring immediate reconstitution with a liquid diluent prior to administration. This preparation is a prescription-only medicine that must be administered by a healthcare professional, unlike many oral antibiotics. The unique inclusion of the benzathine component creates a poorly soluble salt, which is key to its pharmaceutical design. This formulation results in a specialized preparation known as a depot penicillin, intended for deep intramuscular (IM) injection.

Primary Function and General Benefit

The overall function of Benzetacil is the targeted elimination of susceptible bacteria throughout the body. The fundamental benefit provided by the formulation is its ability to achieve prolonged therapeutic concentrations of the antibiotic in the bloodstream. This long-acting property is clinically recognized for ensuring compliance and continuous antibiotic coverage over an extended period. The resulting therapeutic continuity is crucial for achieving complete bacterial eradication, which is necessary for managing certain systemic infections and for prophylactic use in high-risk groups.

Regulatory References

  1. WHO Essential Medicines List for Benzathine Benzylpenicillin

What side effects are possible with Benzetacil?

Possible Side Effects and Safety Information

The safety profile for Benzathine Benzylpenicillin is critically defined by risks associated with the penicillin class and the unique administration requirements of its depot formulation. The official documentation classifies potential effects across several body systems, focusing on hypersensitivity and procedural constraints.

Official Adverse Reaction Groupings

Adverse reactions are formally grouped by regulatory agencies into System-Organ Classes (SOC), including Immune System Disorders, Skin and Subcutaneous Tissue Disorders, Gastrointestinal Disorders, Nervous System Disorders, and Blood and Lymphatic System Disorders. Frequency classifications often use terms like Rare or Not Known for many systemic effects.

Serious Safety Considerations

Regulatory labels document the potential for Anaphylactic Shock, which is a severe, life-threatening allergic reaction. Severe cutaneous adverse reactions, such as Stevens-Johnson Syndrome (SJS), are also officially listed. A specific safety event, the Jarisch-Herxheimer reaction, is documented to occur, typically within the first 24 hours of treatment for spirochete infections.

Administration and Population-Specific Notes

A critical safety restriction is that Benzetacil is for deep intramuscular (IM) injection only. Accidental intravenous or intra-arterial administration is strictly prohibited due to the documented risk of severe neurovascular damage. The official label also notes specific risks for patients with renal impairment, where slower clearance may increase the potential for neurotoxicity.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory information for Benzathine Benzylpenicillin focuses on the potential for severe neurotoxicity resulting from over-exposure.


Documented Overdose Manifestations

Classification Manifestations and Risk Factors
CNS Effects Overdose may be characterized by the onset of convulsive seizures and signs of neuromuscular hyperirritability [FDA Labeling].
Severe Outcomes The potential for encephalopathy is documented, which may present as confusion, impaired consciousness, or abnormal movements [SmPC/EMC].
Population Risk The risk of neurotoxicity is explicitly heightened in patients with impaired renal function due to reduced drug clearance [SmPC/EMC/FDA].

Required Emergency Actions

The onset of these severe neurological signs dictates the immediate and mandatory action of seeking professional medical care.

  • Seek emergency medical attention or call the Poison Help line if overdose is suspected [MedlinePlus/FDA].
  • Immediate contact with emergency services is required if the victim has collapsed, had a seizure, or is unable to be awakened [MedlinePlus].

Official management focuses on symptomatic and supportive treatment; specific monitoring of renal, hepatic, and blood function may be necessary during prolonged exposure [SmPC/EMC]. Regulatory documentation does not list a specific chemical antidote.

Therapeutic Uses of Benzetacil

What Benzetacil Treats: Main Uses and Benefits

Benzetacil (Benzathine Benzylpenicillin) is a medication applied in clinical contexts where supportive symptom management is appropriate for certain conditions. It is relevant in contexts involving heightened systemic burden across domains where additional symptomatic support is needed. This approach provides support that helps ease the overall symptom burden associated with these conditions.

The medication may be part of symptomatic management for conditions that are commonly grouped by their manifestations, such as acute, mild-to-moderate upper-respiratory tract infections, venereal infections like syphilis, and as prophylaxis for serious conditions like rheumatic fever and chorea.

In managing these conditions, Benzetacil assists with maintaining functional stability in clinical settings that involve acute or unstable symptom patterns. It is used in areas where short-term symptom management is appropriate, particularly when symptoms create noticeable functional strain.

“It helps address symptom clusters that may become intense or disruptive, contributing to improved comfort during periods of heightened symptoms.”

Quick Fact: Addresses Symptoms Related to Physical Discomfort

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Benzetacil — Official Regulatory Information

Eligibility Scope

Category Official Regulatory Status (Based on Labeling)
Populations for whom use is contraindicated Patients with a history of a previous severe hypersensitivity reaction to any penicillin or to cephalosporins. Patients with a known allergy to soya or peanut (in specific formulations).
Eligibility-related restrictions Must never be administered intravenously (IV); this route of administration is absolutely prohibited.
Age-related eligibility rules Adults and adolescents are eligible for standard use. Children and neonates are eligible, with usage guided by specific age and weight criteria.
Condition-specific eligibility rules Use requires caution in patients with impaired renal function due to delayed drug clearance. Caution is also necessary for patients with impaired hepatic function and those with a history of allergic diathesis or bronchial asthma.
Pregnancy and lactation eligibility status Use during pregnancy and lactation is generally considered permissible when clinically indicated, though trace amounts are known to be excreted in human milk.

Connection to the Overall Eligibility Profile

Regulatory documents strictly define eligibility by imposing absolute exclusions based on a patient's hypersensitivity status and by mandating a restricted intramuscular route of administration. Eligibility for most other populations is permitted, but requires caution when underlying conditions, such as impaired organ function, are present.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

Official regulatory documents define the interaction profile of Benzathine Benzylpenicillin (Benzetacil) primarily through effects on drug clearance and pharmacodynamic interactions.

Documented Pharmacokinetic Interactions

Interactions that alter drug exposure mainly involve agents that affect renal tubular secretion. Probenecid is known to inhibit the renal tubular excretion of penicillin G, resulting in significantly increased and prolonged concentrations of the antibiotic in the bloodstream. Conversely, Benzathine Benzylpenicillin may reduce the renal clearance of other medications, such as Methotrexate, leading to elevated plasma concentrations of the co-administered drug.

Documented Pharmacodynamic Interactions

These interactions involve combined or opposing effects. Regulatory information indicates that combining Benzathine Benzylpenicillin with bacteriostatic antibiotics (e.g., tetracyclines or chloramphenicol) may lead to antagonism, potentially reducing the penicillin’s bactericidal effectiveness. A notable interaction exists with anticoagulants (e.g., warfarin), where co-administration can increase the risk of bleeding, requiring close monitoring.

Population and General Considerations

No explicit timing-based separation requirements for administration are noted in official labeling for the injectable form. The risk and severity of these interactions are heightened in patients with renal impairment, where the natural clearance of penicillin G is already reduced.

Mechanism of Action

The core mechanism of Benzathine Benzylpenicillin is its targeted action on the invading bacteria's structural integrity, resulting in the destruction of susceptible bacterial cells. This mechanism operates across distinct biological domains to achieve its physiological consequence.

Irreversible Blockade of Cell Wall Assembly

The active ingredient acts as an irreversible inhibitor of bacterial enzymes called Penicillin-Binding Proteins (PBPs), which are crucial for the final cross-linking of the peptidoglycan cell wall. The drug covalently binds to these enzymes, preventing the bacteria from completing their structural construction. This highly selective affinity for bacterial PBPs characterizes the molecular cascade.

Triggering of Osmotic Lysis

Inactivating the PBPs does not just halt construction; it also triggers the activation of the bacteria's own autolytic enzymes. This uncontrolled internal degradation, combined with the structural weakness, compromises the bacteria's defense against internal pressure. The resulting osmotic lysis is a physiological consequence that produces a bactericidal effect on the susceptible bacterial cell.

Mechanism Constraints and Biological Limits

The drug's mechanism is inherently limited by the specific requirement for a peptidoglycan cell wall, making it ineffective against pathogens that naturally lack this structure. Furthermore, the action can be neutralized by bacterial beta-lactamase enzymes, which chemically destroy the antibiotic molecule, thereby rendering the drug unable to engage its PBP target.

Dosage and Administration Information

Administration Guidelines for Benzetacil (Benzathine Benzylpenicillin)

Benzetacil is administered exclusively by deep intramuscular (IM) injection. It must never be injected intravenously (IV) or near a major artery or nerve, due to the risk of severe neurovascular damage. The medication is a powder that must be reconstituted immediately before use with the provided solvent to form a suspension.

Official Dosing and Frequency

The required dose and frequency are strictly determined by the patient's condition and age. Dosing may be a single dose for some acute infections or, for prophylaxis (e.g., rheumatic fever), it may be required every three to four weeks.

Age Group Sample Dosing (I.U.) Frequency
Adults/Adolescents 1.2 Million or 2.4 Million Single dose or every 3–4 weeks
Children (>30 kg) 1.2 Million Single dose or every 3–4 weeks
Children (<30 kg) 0.6 Million Single dose or every 3–4 weeks
Neonates/Infants 50,000 IU/kg Single dose

Procedural and Site Rules

For adults and adolescents, the injection site must be the upper outer quadrant of the gluteus maximus or the ventro-gluteal region. In children and infants, the preferred site is the mid-lateral side of the thigh.

When a large volume (e.g., 2.4 Million I.U.) is administered, the dose must be divided and given at two separate injection sites. The injection should be performed slowly and with low pressure, and aspiration must be performed before administration to ensure a blood vessel has not been entered. The site of injection must be rotated for repeated doses.

Recent Clinical Evidence

Research evidence / Overview of Studies for Benzetacil


Evidence for Use in Acute Streptococcal Infections

Research has explored the use of Benzathine Benzylpenicillin in acute, mild-to-moderate upper respiratory tract infections associated with certain susceptible bacteria. The core evidence for this use was established through early comparative trials and regulatory data reviews that provided supporting data for the indication. These investigations were used in research exploring adult and pediatric populations. The primary outcomes measured included bacteriological response—the measured change in the target organism's presence—and the clinical response observed during the acute phase.

Results related to this indication primarily focus on the acute period. Consequently, follow-up durations were limited to the immediate period of symptom resolution. While the evidence quality is generally consistent with a High level for established clinical use against the target pathogen, modern data often focuses on comparative evidence against alternative treatments, rather than primary efficacy studies.


Evidence for Use in Syphilis Treatment

Benzathine Benzylpenicillin was studied for its role as an intervention across various stages of syphilis, a condition characterized by fluctuating manifestations. Research has included Phase 4 randomized comparative trials (RCTs), large observational cohort studies, and systematic reviews. The populations was evaluated in include adults (with and without co-existing conditions like HIV), pregnant women, and neonates for managing congenital syphilis.


Evidence for Secondary Disease Prophylaxis

Research has extensively examined the use of Benzathine Benzylpenicillin for secondary prophylaxis in conditions characterized by cycles of stability and flare-ups, such as the recurrence of Rheumatic Fever and the progression of Rheumatic Heart Disease (RHD). Studies explored this use in children and adolescents. These studies monitored outcomes reflecting daily functioning or activity level and observed the rates of clinical recurrence over extended periods.


Research Gaps and Areas of Uncertainty

The evidence landscape for these indications still contains areas where data are insufficient or research is ongoing. A key limitation noted is the discordance between pharmacokinetic measurements (drug levels in the blood) and the observed long-term clinical prevention results in prophylaxis trials. This means further investigation is needed to fully understand the precise biological mechanism linking drug concentration to clinical outcome over the long term. Research provides context but not individual predictions, and the results apply only to the specific conditions and populations studied.

Key Studies & References

  1. WHO Model List of Essential Medicines (MLEM)
  2. MedlinePlus Drug Information: Penicillin G Benzathine Injection

Frequently Asked Questions (FAQ)

Common questions about Benzetacil (FAQ)

Q: How quickly does Benzetacil start working?

A: Official information describes this medication as a depot formulation, meaning it is specifically designed for slow, prolonged release. The purpose of this design is to achieve and maintain therapeutic concentrations of the active ingredient over an extended period, rather than achieving rapid peak levels.

Q: How long does the effect of one Benzetacil injection last?

A: The drug is designed to maintain effective concentrations in the bloodstream for a long duration. Official regulatory documents indicate that for some long-term conditions, such as prophylaxis (preventive treatment), continuous coverage is described as extending up to three to four weeks.

Q: Can Benzetacil cause an allergic reaction in someone who has never had one before?

A: Official safety documents list severe allergic reactions, including life-threatening anaphylactic shock, as a documented potential risk associated with the use of penicillin-class drugs. The possibility of an allergic reaction is present even if a person has never received the medication before.

Q: Is Benzetacil safe for use during pregnancy?

A: Regulatory documents indicate that the use of this medication during pregnancy is generally permissible when clinically indicated. It is a standard treatment that has been used for certain infections in pregnant individuals.

Q: Can Benzetacil cause issues with gut flora or digestion?

A: Official safety documents list general Gastrointestinal Disorders as potential adverse reactions, which can include digestive issues. Furthermore, regulatory warnings for antibiotics, in general, include the possibility of a severe form of diarrhea (colitis) that may occur during or even months after administration.

Q: Does Benzetacil affect the results of any common lab tests?

A: Official regulatory documents describe the potential for the active ingredient, Benzathine Benzylpenicillin, to interfere with the accuracy of certain types of laboratory tests. This possibility is noted in the product information.

Q: Can children receive Benzetacil?

A: Official regulatory guidelines confirm that children and neonates (newborns) are part of the eligible population for this medication. The use and administration are guided by the specific condition being treated, as well as the child’s age and weight.

Q: Is it normal to feel pain at the injection site after getting Benzetacil?

A: Official safety information for this long-acting injection documents that localized injection site pain, swelling, and inflammation are described as common local reactions. This is often associated with the depot formulation designed for slow release within the muscle.

Q: Why is Benzetacil sometimes prescribed for rheumatic fever prevention?

A: This medication is used for prevention, or secondary prophylaxis, because its specialized long-acting depot formulation is able to continuously maintain therapeutic levels of the antibiotic in the bloodstream. This prolonged coverage is crucial for preventing the recurrence of certain infections.

Q: Why are some people afraid of the Benzetacil shot?

A: The official safety warnings emphasize that the medication must be injected strictly into the muscle only (deep intramuscular injection). This strict instruction is due to the documented risk of severe injury, including neurovascular damage, if the drug is accidentally injected into a blood vessel or near a nerve.

Q: Is there a risk of developing antibiotic resistance with Benzetacil?

A: The issue of antibiotic resistance is a concern with all anti-infective agents. Regulatory documents describe that certain bacterial enzymes, known as beta-lactamase, have the capacity to chemically neutralize the drug’s activity, which is the mechanism of resistance specific to this drug class.

Q: Why does the injection fluid look cloudy sometimes?

A: The medication is supplied as a powder that must be mixed with a diluent to create a suspension immediately before administration. Because it is a suspension, the mixed fluid is expected to appear opaque or cloudy, and should not be clear like a typical liquid solution.

Q: Is Benzetacil a broad-spectrum antibiotic?

A: Official indications and the drug's mechanism of action define it as a penicillin-class antibiotic primarily used for infections caused by specific, susceptible bacteria, such as certain Gram-positive organisms. It is not generally classified as a broad-spectrum agent.

Q: Are there any long-term side effects from Benzetacil?

A: Official documentation describes the potential for some adverse reactions to have a delayed or persistent presentation. For example, a severe form of diarrhea (colitis) is documented as potentially occurring weeks or months after administration.

Q: Does Benzetacil interact with any common over-the-counter pain relievers?

A: Regulatory documents describe potential drug-drug interactions that involve specific over-the-counter pain-relieving ingredients. This information is available in the official product labeling.

Q: What should I do if I miss a scheduled Benzetacil injection?

A: Guidance for a missed scheduled injection is highly specific and is determined by the condition being treated (such as syphilis or rheumatic fever prophylaxis) and the individual's status. The required management strategy is complex and depends on a professional clinical assessment.

Q: How is Benzetacil different from amoxicillin?

A: Both are penicillin-class antibiotics, but the key difference lies in their formulation and pharmacological properties. Benzetacil is a long-acting depot injection designed for continuous coverage, while amoxicillin is typically an oral formulation with a much shorter duration of action.

Q: Are there studies comparing the long-term effectiveness of Benzetacil versus oral antibiotics for certain conditions?

A: Yes, regulatory evidence reviews include clinical studies that compare the effectiveness of this long-acting injection to alternative oral antibiotic treatments for specific conditions. This comparative data is used to support the established medical indications.

Q: Can a person be allergic to Benzetacil without being allergic to regular penicillin G?

A: Official product information notes that some specific formulations contain non-penicillin components, known as excipients. Allergies may sometimes be linked to these other ingredients, such as soy lecithin, and this possibility is noted in official documentation as a contraindication for certain patients.

Q: Can Benzetacil cause a fever?

A: Fever is listed in official safety documentation as a potential adverse reaction. It is also a key symptom of the Jarisch-Herxheimer reaction, which is noted to occur during treatment for certain spirochete infections.

Q: Has Benzetacil been studied in different ethnic populations?

A: Clinical trials and research reviewed by regulatory bodies include diverse populations globally. This focus is particularly evident in studies related to diseases the drug treats, such as Rheumatic Heart Disease, which disproportionately affects certain regions and populations.

How should Benzetacil be stored and disposed of?

Storage and Disposal of Benzetacil (Benzathine Benzylpenicillin)

The official storage and disposal requirements for this medication are defined by regulatory authorities to maintain its stability and ensure public safety.


Storage Conditions

Requirement Specifics as per Regulatory Labeling
Temperature The injectable suspension must be stored in a refrigerator (2 C to 8 C). The powder form is typically stored at controlled room temperature (below 30 C).
Environmental Product must be kept in the original container to protect it from light and moisture. The suspension must not freeze.
Stability The suspension is for immediate use only following reconstitution; do not store the mixed product.
Child Safety Must be stored out of the sight and reach of children.

Disposal Instructions

Unused or expired product must be disposed of in accordance with local regulations for pharmaceutical waste. The product should not be disposed of via wastewater or household waste. All used needles and syringes associated with administration must be placed in a designated sharps disposal container.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Benzetacil found in:

A-Z Index: